DD Stock Analysis: Dupont De Nemours | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 20.503m USD | 12M Return: 28.5% | US26614N2018 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 150M
EPS Trend: -45.7%
Qual. Beats: 3
Rev. Trend: -75.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
DuPont de Nemours, Inc. (NYSE: DD) is a technology-based materials and solutions provider operating across the United States, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company is organized into two reporting segments: Healthcare & Water Technologies and Diversified Industrials, reflecting its diversified chemicals classification within the broader Materials sector.
Within Healthcare & Water Technologies, DuPont supplies specialty components for medical devices, packaging, and protective garments under the well-known TYVEK brand. It also provides water filtration and separation solutions, including elements, modules, and systems for industrial wastewater, energy, municipal, desalination, and life sciences applications. Key product lines include AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules-addressing the growing global demand for water purification and industrial separation technologies.
The Diversified Industrials segment serves construction markets with engineered products such as TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface, spanning non-residential, residential, and repair-and-remodel applications. DuPont also designs and produces engineered components and process solutions for OEM and operational end markets including automotive, aerospace, printing, and packaging. Notable offerings include Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates-products commonly used in advanced manufacturing and industrial supply chains.
DuPont was formerly known as DowDuPont Inc. and adopted its current name in June 2019 following the corporate separation of Dow and DuPont. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware, and trades as a large-cap stock on the NYSE.
- Electronics materials revenue surges on AI semiconductor cycle
- Water Technologies margins expand from industrial and life sciences demand
- Construction weakness pressures Diversified Industrials segment margins
| Net Income: 301.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.92 > 1.0 |
| NWC/Revenue: 38.66% < 20% (prev 40.17%; Δ -1.51% < -1%) |
| CFO/TA 0.05 > 3% & CFO 982.0m > Net Income 301.0m |
| Net Debt (1.45b) to EBITDA (1.29b): 1.12 < 3 |
| Current Ratio: 2.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (135.1m) vs 12m ago -3.52% < -2% |
| Gross Margin: 34.49% > 18% (prev 33.07%; Δ 1.42% > 0.5%) |
| Asset Turnover: 24.00% > 50% (prev 32.82%; Δ -8.83% > 0%) |
| Interest Coverage Ratio: 3.68 > 6 (EBIT TTM 670.0m / Interest Expense TTM 182.0m) |
| A: 0.13 (Total Current Assets 4.74b - Total Current Liabilities 2.01b) / Total Assets 20.8b |
| B: -1.18 (Retained Earnings -24.5b / Total Assets 20.8b) |
| C: 0.02 (EBIT TTM 670.0m / Avg Total Assets 29.4b) |
| D: 1.91 (Book Value of Equity 13.6b / Total Liabilities 7.12b) |
| Altman-Z'' = -0.83 = CCC |
| DSRI: 1.29 (Receivables 1.73b/2.37b, Revenue 7.06b/12.5b) |
| GMI: 0.96 (GM 33.07% / 34.49%) |
| AQI: 1.03 (AQ_t 0.61 / AQ_t-1 0.59) |
| SGI: 0.57 (Revenue 7.06b / 12.5b) |
| TATA: -0.03 (NI 301.0m - CFO 982.0m) / TA 20.8b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of November 14, 2026, the stock is trading at USD 153.78 with a total of 1,114,687 shares traded. Over the past week, the price has changed by +4.95%, over one month by +18.70%, over three months by +7.19% and over the past year by +28.48%.
Current recommended Stop Loss: 148.90 (which is 3.2% or 1.2 ATR below the current price).
Dupont De Nemours has received a consensus analysts rating of 4.39. Therefore, it is recommended to buy DD.
- StrongBuy: 11
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 172.5 | 12.2% |
P/E Trailing = 53.9024
P/E Forward = 19.3424
P/S = 2.9037
P/B = 1.5194
P/EG = 0.7833
Revenue TTM = 7.06b USD
EBIT TTM = 670.0m USD
EBITDA TTM = 1.29b USD
Long Term Debt = 3.09b USD (from longTermDebt, last quarter)
Short Term Debt = 60.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 9.00m
Net Debt = 1.45b USD (calculated: Debt 3.10b - CCE 1.65b)
Enterprise Value = 22.0b USD (20.5b + Debt 3.10b - CCE 1.65b)
Interest Coverage Ratio = 3.68 (Ebit TTM 670.0m / Interest Expense TTM 182.0m)
EV/FCF = 24.86x (Enterprise Value 22.0b / FCF TTM 883.0m)
FCF Yield = 4.02% (FCF TTM 883.0m / Enterprise Value 22.0b)
FCF Margin = 12.51% (FCF TTM 883.0m / Revenue TTM 7.06b)
Net Margin = 4.26% (Net Income TTM 301.0m / Revenue TTM 7.06b)
Gross Margin = 34.49% ((Revenue TTM 7.06b - Cost of Revenue TTM 4.63b) / Revenue TTM)
Gross Margin QoQ = 35.71% (prev 35.13%)
Tobins Q-Ratio = 1.06 (Enterprise Value 22.0b / Total Assets 20.8b)
Interest Expense / Debt = 5.87% (Interest Expense 182.0m / Debt 3.10b)
Taxrate = 38.79% (256.0m / 660.0m)
NOPAT = 410.1m (EBIT 670.0m * (1 - 38.79%))
Current Ratio = 2.36 (Total Current Assets 4.74b / Total Current Liabilities 2.01b)
Debt / Equity = 0.23 (Debt 3.10b / totalStockholderEquity, last quarter 13.6b)
Debt / EBITDA = 1.12 (Net Debt 1.45b / EBITDA 1.29b)
Debt / FCF = 1.64 (Net Debt 1.45b / FCF TTM 883.0m)
Total Stockholder Equity = 13.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.02% (Net Income 301.0m / Total Assets 20.8b)
RoE = 2.18% (Net Income TTM 301.0m / Total Stockholder Equity 13.8b)
RoCE = 3.96% (EBIT 670.0m / Capital Employed (Equity 13.8b + L.T.Debt 3.09b))
RoIC = 2.22% (NOPAT 410.1m / Invested Capital 18.5b)
WACC = 8.87% (E(20.5b)/V(23.6b) * Re(9.67%) + D(3.10b)/V(23.6b) * Rd(5.87%) * (1-Tc(0.39)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -83.76 | Cagr: -1.50%
[DCF] Terminal Value 71.17% ; FCFF base≈1.03b ; Y1≈907.6m ; Y5≈733.3m
[DCF] Fair Price = 70.84 (EV 10.8b - Net Debt 1.45b = Equity 9.39b / Shares 132.5m; r=8.87% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -45.72 | EPS CAGR: -9.38% | SUE: 1.65 | # QB: 3
Revenue Correlation: -75.42 | Revenue CAGR: -14.24% | SUE: 0.05 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.83 | Chg30d=+3.31% | Revisions=+25% | Analysts=7
EPS current Year (2026-12-31): EPS=7.52 | Chg30d=+3.71% | Revisions=+55% | GrowthEPS=+49.3% | GrowthRev=+5.0%
EPS next Year (2027-12-31): EPS=8.17 | Chg30d=+2.69% | Revisions=+75% | GrowthEPS=+8.6% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +76% (up=17, down=1)